Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer

Critical Reviews in Oncology/Hematology

Volumn 29, Issue 3, 1999, Pages 209-248

  Jiang, Wen ^a   Hiscox, Stephen ^a   Matsumoto, Kunio ^b   Nakamura, Toshikazu ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CELL ADHESION MOLECULE; GAMMA LINOLENIC ACID; INTERLEUKIN 12; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; RETINOIC ACID; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

AUTOCRINE EFFECT; BRAIN TUMOR; BREAST CANCER; CANCER; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL MOTILITY; DIGESTIVE SYSTEM CANCER; DRUG TARGETING; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; LIVER CANCER; LUNG CANCER; METASTASIS; MOLECULAR BIOLOGY; NERVOUS SYSTEM TUMOR; NONHUMAN; ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; STOMACH CANCER; THYROID CANCER; TISSUE INTERACTION; TUMOR VASCULARIZATION; URINARY TRACT CANCER;

EID: 0032946931     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(98)00019-5     Document Type: Article

References (376)

1. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem Biophys Res Commun. 122:1984;1450-1459.
2. Michalopoulos G., Houck K.A., Dolan M.L. et al. Control of hepatocyte replication by two serum factors. Cancer Res. 44:1984;4414-4419.
3. Russell W.E., McGowan J.A., Bucher N.L.R. Partial characterization of an hepatocyte growth factor from rat platelets. J Cell Physiol. 119:1984;183-192.
4. Nakamura T., Nishizawa T., Hagiya M. et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1989;440-443.
5. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res. 3:1991;67-85.
6. 2-terminal amino acid sequence of rabbit hepatopoitin A, a heparin binding polypeptide growth factor for hepatocytes. Biochem Biophys Res Commun. 163:1989;1370-1376.
7. Zarnegar R., Muga S., Rahija R., Michalopoulos G.M. Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA. 87:1990;1252-1256.
8. Higashio K., Shima N., Goto M. et al. Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem Biophys Res Commun. 170:1990;397-404.
9. Stoker M., Perryman M. An epithelial scatter factor released by embryo fibroblasts. J Cell Sci. 77:1985;209-223.
10. Weidner K.M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 111:1990;2097-2108.
11. Weidner K.M., Arakaki N., Hartmann G. et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA. 88:1991;7001-7005.
12. Gherardi E., Stoker M. Hepatocyte and scatter factor. Nature. 346:1990;228.
13. Furlong R.A., Takehara T., Taylor W.G. et al. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci. 100:1991;173-177.
14. Miyazawa K., Shimomura T., Naka D. et al. Proteolytic activation of hepatocyte growth-factor in response to tissue-injury. J Biol Chem. 269:1994;8966-8970.
15. Naldini L., Weidner K.M., Vigna E. et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 10:1991;2867-2878.
16. Naldini L., Vigna E., Bardelli A. et al. Biological activation of pro-HGF (hepatocyte growth-factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem. 270:1995;603-611.
17. Mizuno K., Tanoue Y., Okano I. et al. Purification and characterization of hepatocyte growth-factor (HGF)-converting enzyme-activation of pro-HGF. Biochem Biophys Res Commun. 198:1994;1161-1169.
18. Shimomura T., Kondo J., Ochiai M. et al. Activation of the zymogen of hepatocyte growth-factor activator by thrombin. J Biol Chem. 268:1993;22927-22932.
19. Mars W.M., Zarnegar R., Michalopoulos G.K. Activation of hepatocyte growth-factor by the plasminogen activators uPA and tPA. Am J Pathol. 143:1993;949-958.
20. Mars W.M., Liu M.L., Kitson R.P. et al. Immediate-early detection of urokinase receptor after partial-hepatectomy and its implications for initiation of liver- regeneration. Hepatology. 21:1995;1695-1701.
21. Matsumoto K., Takehara T., Inoue H. et al. Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities. Biochem Biophys Res Commun. 181:1991;691-699.
22. Lerch P.G., Rickli E.E., Lergier W., Gillessen D. Localisation of individual lysine binding regions in human plasminogen and investigations on their complex forming properties. Eur J Biochem. 107:1980;7-13.
23. van Zonneveld A.J., Veerman H., Pannekoek H. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. J Biol Chem. 261:1986;14214-14218.
24. Strain A.J. Hepatocyte growth factor: another ubiquitous cytokine. J Endocrinol. 137:1993;1.
25. Fukuyama R, Ichijoh Y, Minoshima S, et al. Regional localization of the hepatocyte growth factor (HGF) gene to human chromosome 7 band p 21.1. Genomics 1991;11:410-415.
26. Seki T., Hagiya M., Shimonishi M. et al. Organization of the human hepatocyte growth factor-encoding gene. Gene. 102:1991;213-219.
27. Shimamoto A., Kimura T., Matsumoto K., Nakamura T. Hepatocyte growth factor-like protein is identical to macrophage stimulating protein. FEBS Lett. 333:1993;61-66.
28. Wang M.H., Skeel A., Yoshimura T. et al. Antibodies to macrophage stimulating protein (MSP) - specificity, epitope interactions, and immunoassay of msp in human serum. J Leukoc Biol. 54:1993;289-295.
29. Yoshimura T., Yuhki N., Wang M.H. et al. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms msp as a member of the family of kringle proteins and locates the msp gene on chromosome-3. J Biol Chem. 268:1993;15461-15468.
30. Donate L.E., Gherardi E., Srinivasan N. et al. Molecular evolution and domain-structure of plasminogen-related growth-factors (HGF/SF and HGF1/MSP). Protein Sci. 3:1994;2378-2394.
31. Bottaro D.P., Rubin J.S., Faletto D.L. et al. Identification of the hepatocyte growth factor as the c-met protooncogene product. Science. 258:1991;802-804.
32. Cooper C.S., Park M., Blair D.G. et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 311:1984;29-33.
33. Giordano S., Zhen Z., Medico E. et al. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc Natl Acad Sci USA. 90:1993;649-653.
34. Park M., Dean M., Kaul K. et al. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine family of growth factor receptors. Proc Natl Acad Sci USA. 84:1987;6379-6383.
35. Ronsin C., Muscatelli F., Mattei M.G. et al. A novel putative receptor protein tyrosine kinase of the met family. Oncogene. 8:1993;1195-1202.
36. Gaudino G., Follenzi A., Naldini L. et al. Ron is a heterodimeric tyrosine kinase receptor-activated by the HGF homolog MSP. EMBO J. 13:1994;3524-3532.
37. Ponzetto C., Bardelli A., Zhen Z. et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth-factor scatter factor-receptor family. Cell. 77:1994;261-271.
38. Huff J.L., Jelinek M.A., Borgman C.A., Lansing T.J. The protooncogene c-sea encodes a transmembrane protein tyrosine kinase related to the met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci USA. 90:1994;6140-6144.
39. Wang M.H., Ronsin C., Gesnel M.C. et al. Identification of the ron gene-product as the receptor for the human macrophage stimulating protein. Science. 266:1994;117-119.
40. Li B.Q., Wang M.H., Kung H.F. et al. Macrophage stimulating protein activates ras by both activation and translocation of SOS nucleotide exchange factor. Biochem Biophys Res Commun. 216:1995;110-118.
41. Faletto D.L., Kaplan D.R., Halverson D.O. et al. Signal transduction in c-met mediated motogenesis. Goldberg I.D., Rosen E.M. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the c-met receptor. 1993;107-130 Birkhauser, Basel.
42. Ponzetto C., Bardelli A., Maina F. et al. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth- factor scatter factor-receptor. Mol Cell Biol. 13:1993;4600-4608.
43. Pawson T., Gish C.D. SH2 and SH3 domains: from structure to function. Cell. 71:1992;359-362.
44. Koch C.A., Anderson D., Moran M.F. et al. SH2 and SH3 domains, elements that controll interactions of cytoplasmic signalling proteins. Science. 252:1991;668-674.
45. Songyang Z., Shoelson S.E., Chaudhuri M. et al. SH2 domains recognise specific phophopeptide sequences. Cell. 72:1993;767-778.
46. Songyang Z., Gish G., Mbamalu G. et al. A single-point mutation switches the specificity of group-iii src homology (SH) 2 domains to that of group-i sh2 domains. J Biol Chem. 270:1995;26029-26032.
47. Okano Y., Mizuno K., Osada S., Nakamura T., Nozawa Y. Tyrosine phosphorylation of phosphlipase C gamma in c-met/ HGF receptor-stimulated hepatocytes: comparison with HepG2 hepatocarcinoma cells. Biochem Biophys Res Commun. 190:1993;842-848.
48. Chen P., Xie H., Sekar M.C., Gupta K., Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol. 127:1994;847-857.
49. Chen P., Murphy-Ullrich J.E., Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol. 134:1996;689-698.
50. Adachi T., Nakashima S., Saji S. et al. Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation. Hepatology. 21:1995;1668-1674.
51. Pelicci G., Giordano S., Zhen Z. et al. The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene. 10:1995;1631-1638.
52. Nobles C.D., Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81:1995;53-62.
53. Takaishi K., Kikuchi A., Kuroda S. et al. Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility. Mol Cell Biol. 13:1993;72-79.
54. Miura Y., Kikuchi A., Musha T. et al. Regulation of morphology by rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in Swiss 3T3 cells. J Biol Chem. 268:1993;510-515.
55. Chong L.D., Traynor-Kaplan A., Bokoch G.M., Schwartz M.A. The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells. Cell. 79:1994;507-513.
56. Corps A.N., Sowter H.M., Smith S.K. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met. Int J Cancer. 73:1997;151-155.
57. Sugawara J., Fukaya T., Murakami T. et al. Hepatocyte growth factor stimulates proliferation, migration, and lumen formation of human endometrial epithelial cells in vitro. Biol Reprod. 57:1997;936-942.
58. Pagan R., Martin I., Llobera M. et al. Growth and differentiation factors inhibit the migratory phenotype of cultured neonatal rat hepatocytes induced by HGF/SF. Exp Cell Res. 235:1997;170-179.
59. Weimar I.S., Muller E.J., Dejong D. et al. Hepatocyte growth-factor and its receptor are involved in migration of lymphoma-cells. Exp Hematol. 23:1995;917.
60. Kaji M., Yonemura Y., Harada S. et al. Participation of c-met in the progression of human gastric cancers: Anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells. Cancer Gene Ther. 3:1996;393-404.
61. Kobayashi T., Honke K., Gasa S. et al. Hepatocyte growth-factor elevates the activity levels of glycolipid sulfotransferases in renal-cell carcinoma-cells. Eur J Biochem. 219:1994;407-413.
62. Hasegawa Y., Yamamoto M., Maeda S., Saitoh Y. Hepatocyte growth-factor and its receptor c-met regulate both cell-growth and invasion of human pancreatic-cancer. Int J Oncol. 7:1995;877-881.
63. Direnzo M.F., Poulsom R., Olivero M. et al. Expression of the met hepatocyte growth-factor receptor in human pancreatic-cancer. Cancer Res. 55:1995;1129-1138.
64. Humphrey P.A., Zhu X.P., Zarnegar R. et al. Hepatocyte growth-factor and its receptor (c-met) in prostatic-carcinoma. Am J Pathol. 147:1995;386-396.
65. Jiang W.G., Lloyd D., Puntis M.C.A. et al. Regulation of spreading and growth of human colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis. 11:1993;235-242.
66. Jiang W.G., Puntis M.C.A., Hallett M.B. Monocyte conditioned media possess a novel factor which increases motility of cancer cells. Int J Cancer. 53:1993;426-431.
67. Gulati R., Peluso J.J. Opposing actions of hepatocyte growth factor and basic fibroblast growth factor on cell contact, intracellular free calcium levels, and rat ovarian surface epithelial cell viability. Endocrinology. 138:1997;1847-1856.
68. Tajima H., Matsumoto K., Nakamura T. Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett. 291:1991;229-232.
69. Shiota G., Kawasaki H., Nakamura T. et al. Inhibitory effect of hepatocyte growth-factor against fao hepatocellular-carcinoma cells may be associated with changes of intracellular signaling pathways mediated by protein-kinase-C. Res Commun Mol Pathol Pharmacol. 85:1994;271-278.
70. Yanagawa K., Yada K., Takeuch K. et al. Induction of apoptosis by hepatocyte growth-factor (HGF) and interferon-gamma (IFN-gamma) in hep g2 cells. Gastroenterology. 108:1995;1203.
71. Iwama A., Yamaguchi N., Suda T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the hgf receptor family. EMBO J. 15:1996;5866-5875.
72. Bardelli A., Longati P., Albero D. et al. HGF receptor associates with the anti-apoptotic protein bag-1 and prevents cell-death. EMBO J. 15:1996;6205-6212.
73. Liu S.I., Lui W.Y., Mok K.T. et al. Effect of hepatocyte growth factor on cell cycle and c-met expression in human gastric cancer cells. Anticancer Res. 17:1997;3575-3580.
74. Stracke M.L., Liotta L.A. Mendelson J., Howley P.M., Israel M.A., Liotta L.A. The Molecular Basis of Cancer. 1995;233-247 Saunders, Philadelphia, PA.
75. Jiang W.G., Puntis M.C.A., Hallett M.B. The molecular and cellular basis of cancer invasion and metastasis and its implications for treatment. Br J Surg. 81:1994;1576-1590.
76. Hart I.R., Goode N.T., Wilson R.E. Molecular aspects of the metastatic cascade. Biochim Biophys Acta. 989:1989;65-84.
77. Jiang W.G. E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg. 83:1996;437-446.
78. Shapiro L., Fannon A.M., Kwong P.D. et al. Structural basis of cell-cell adhesion by cadherins. Nature. 374:1995;327-337.
79. Mareel M., Berx G., Van Roy F. et al. Cadherin/catenin complex: a target for antiinvasive therapy? J Cell Biochem. 61:1996;524-530.
80. Jiang W.G., Hiscox S. catenin, cell adhesion and beyond. Int J Oncol. 11:1997;635-641.
81. Stoker M., Gheradi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
82. Stoker M., Gherardi E. Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta. 1072:1991;81-102.
83. Jiang W.G., Hallett M.B., Puntis M.C.A. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastases. Br J Surg. 80:1993;1368-1373.
84. Pasdar M., Li Z., Marreli M. et al. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules. Cell Growth Different. 8:1997;451-462.
85. Hiscox S., Jiang W.G. HGF/SF regulates the phosphorylatin of β-catenin and cell-cell adhesion in cancer cells. Proc Am Assoc Cancer Res 1998;39:500-1.
86. Shibamoto S., Hayakawa M., Takeuchi K. et al. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth-factor and epidermal growth-factor in human carcinoma-cells. Cell Adhes Commun. 1:1994;295-305.
87. Tannapfel A., Yasui W., Yokozaki H. et al. Effect of hepatocyte growth-factor on the expression of E-cadherin and P-cadherin in gastric-carcinoma cell-lines. Virchows Arch. 425:1994;139-144.
88. Watabe M., Matsumoto K., Nakamura T. et al. Cooperative action of hepatocyte growth factor and anti-cadhein antibodies on the scattering of keratinocyte lines. Cell Str Func. 18:1993;117-124.
89. Crepaldi T., Pollack A.L., Prat M. et al. Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial-cells. J Cell Biol. 125:1994;313-320.
90. Hynes R.O. Integrins-versatility, modulation, and signaling in cell-adhesion. Cell. 69:1992;11-25.
91. Schwartz M.A. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol. 120:1993;1003-1010.
92. Pelletier R.P., Ohye R.G., Vanbuskirk A. et al. Importance of endothelial vcam-1 for inflammatory leukocytic infiltration invivo. J Immunol. 149:1992;2473-2481.
93. 2+ in human neutrophils: initiation by adherence receptors of the integrin family. J Cell Biol. 112:1991;1249-1257.
94. Schwartz M.A., Ingber D.E., Lawrence M. et al. Multiple integrins share the ability to induce elevation of intracellular pH. Exp Cell Res. 195:1991;533-535.
95. Guan J.L., Trevithick J.E., Hynes R.O. Fibronectin integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul. 11:1991;951-964.
96. Kornberg L.J., Earp H.S., Turner C.E. et al. Signal transduction by integrins-increased protein tyrosine phosphorylation caused by clustering of beta-1 integrins. Proc Natl Acad Sci USA. 88:1991;8392-8396.
97. Guan J.L., Shalloway D. Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature. 358:1992;690-692.
98. Lipfert L., Haimovich B., Schaller M.D. et al. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol. 119:1992;905-912.
99. Hanks S.K., Calalb M.B., Harper M.C., Patel S.K. Focal adhesion protein tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA. 89:1992;8487-8491.
100. FAK, a structurally distinctive protein tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA. 89:1992;5192-5196.
101. Rossen K., Dahlstrom K.K., Mercurio A.M. et al. Expression of the alpha 6 beta 4 integrin by squamous cell carcinomas and basal cell carcinomas: possible relation to invasive potential? Acta Dermato-Venereologica. 74:1994;101-105.
102. Dedhar S., Saulnier R. Alterations in integrin receptro expression on chemically transformed human cells: specific enhancement of collagen and laminin receptor complexes. J Cell Biol. 110:1990;481-489.
103. Giancotti F.G., Mainiero F. Integrin-mediated adhesion and signalling in tumourogenesis. Biochem Biophys Acta. 1198:1994;47-64.
104. van Leeuwen R.L., Yoshinaga I.G., Akasaka T. et al. Attachment, spreading and migration of melanoma cells on vitronectin. The role of alpha V beta 3 and alpha V beta 5 integrins. Exp Dermatol. 5:1996;308-315.
105. Albelda S.M., Mette S.A., Elder D.E. et al. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 50:1990;6757-6764.
106. Price E.A., Coombe D.R., Murray J.C. Beta-1 integrins mediate tumor-cell adhesion to quiescent endothelial-cells in-vitro. Br J Cancer. 74:1996;1762-1766.
107. Weimar I.S., deJong D., Muller E.J. et al. Hepatocyte growth factor scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha(4)beta(1) and alpha(5)beta(1) integrins. Blood. 89:1997;990-1000.
108. KawakamiKimura N., Narita T., Ohmori K. et al. Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells. Br J Cancer. 75:1997;47-53.
109. Narita T., Mitsuoka C., Kimura N. et al. Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer. Oncol Rep. 6:1997;1239-1241.
110. Jiang W.G., Hiscox S., Nakamura T. et al. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin and enhances cell-matrix interactions. Oncology Rep. 3:1996;819-823.
111. Matsumoto K., Matsumoto K., Nakamura T., Kramer R.H. Hepatocyte growth-factor scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125(FAK)) and promotes migration and invasion by oral squamous-cell carcinoma-cells. J Biol Chem. 269:1994;1807-31813.
112. Besser D., Bardelli A., Didichenko S. et al. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Oncogene. 14:1997;705-711.
113. Morimoto A., Tada K., Nakayama Y. et al. Cooperative roles of hepatocyte growth-factor and plasminogen-activator in tubular morphogenesis by human microvascular endothelial-cells. Jpn J Cancer Res. 85:1994;53-62.
114. Wojta J., Nakamura T., Fabry A. et al. Hepatocyte growth-factor stimulates expression of plasminogen- activator inhibitor type-1 and tissue factor in HEPG2 cells. Blood. 84:1994;151-157.
115. Bennett J.H., Furness J., Atkin P., Speight P.M. Scatter factor (SF) regulation of matrix metalloproteinase production by oral carcinoma cells. J Dental Res. 76:1997;2140.
116. Dunsmore S.E., Rubin J.S., Kovacs So. et al. Mechanisms of hepatocyte growth-factor stimulation of keratinocyte metalloproteinase production. J Biol Chem. 271:1996;24567-24582.
117. Jiang W.G., Hiscox S., Singhrao S.K. et al. Inhibition of HGF/SF induced membrane ruffling and cell motility by transient elevation of cytosolic free calcium. Exp Cell Res. 200:1995;424-433.
118. Dowrick P., Kenworthy P., Mccann B., Warn R. Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth-factor scatter factor-treated cells. Eur J Cell Biol. 61:1993;44-53.
119. Nishiyama T., Sasaki T., Takaishi K. et al. rac p21 is involved in insulin-induced membrane ruffling and rho p21 is involved in hepatocyte growth factor-induced and 12-o-tetradecanoylphorbol-13-acetate (TPA)-induced membrane ruffling in kb cells. Mol Cell Biol. 14:1994;2447-2456.
120. Jiang W.G., Hiscox S., Singhrao S.K. et al. Induction of tyrosine phosphorylation and translocation of ezrin by hepatocyte growth factor (HGF/SF). Biochem Biophys Res Commun. 217:1995;1062-1069.
121. Brinkmann V., Foroutan H., Sachs M. et al. Hepatocyte growth-factor scatter factor induces a variety of tissue-specific morphogenic programs in epithelial-cells. J Cell Biol. 131:1995;1573-1586.
122. Montesano R., Matsumoto K., Nakamura T. et al. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:1991;901-908.
123. Clark P. Modulation of scatter factor hepatocyte growth-factor activity by cell-substratum adhesion. J Cell Sci. 107:1994;1265-1275.
124. Hiscox S., Jiang W.G. Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor. Biochem Biophys Res Commun. 233:1997;1-5.
125. Jiang W.G., Bryce R.P., Horrobin D.F., Mansel R.E. Gamma linolenic acid regulates gap junction communication in endothelial cells and their interaction with tumour cells. Prostagladin Leukotriene Essent Fatty Acid. 56:1997;307-316.
126. Moorby C.D., Stoker M., Gherardi E. HGF/SF inhibits junctional communication. Exp Cell Res. 219:1995;657-663.
127. Rusciano D., Lorenzoni P., Burger M.M. Expression of constitutively activated hepatocyte growth-factor scatter factor-receptor (c-met) in b16 melanoma-cells selected for enhanced liver colonization. Oncogene. 11:1995;1979-1987.
128. Jiang W.G., Hiscox S., Hallett M.B., Bryce R., Horrobin D.F., Mansel R.E., Puntis M.C.A. Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid. Int J Oncol. 9:1996;279-284.
129. Singhkaw P., Zarnegar R., Siegfried J.M. Stimulatory effects of hepatocyte growth-factor on normal and neoplastic human bronchial epithelial-cells. Am J Physiol. 12:1995;L1012-L1020.
130. Harvey P., Warn A., Newman P. et al. Immunoreactivity for hepatocyte growth factor scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas. J Pathol. 180:1996;389-394.
131. Torok N., Urrutia R., Nakamura T., Mcniven M.A. Up-regulation of molecular motor-encoding genes during hepatocyte-growth-factor-induced and epidermal-growth-factor-induced cell motility. J Cell Physiol. 167:1996;422-433.
132. Bussolino F., DiRenzo M.F., Ziche M. et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 119:1992;629-641.
133. Comoglio P.M., Di Renzo M.F., Naldini L. et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial-cell motility and growth. J Cell Biochem. S17A:1993;232.
134. VanBelle E., Witzenbichler B., Chen D.H. et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor - the case for paracrine amplification of angiogenesis. Circulation. 97:1998;381-390.
135. Grant D.S., Kleinman H.K., Goldberg I.D. et al. Scatter factor induces blood-vessel formation in vivo. Proc Natl Acad Sci USA. 90:1993;1937-1941.
136. Rosen E.M., Goldberg I.D., Jaken S., Grant D.S. Regulation of endothelial-cell migration and capillary-like tube formation by scatter factor. Circulation. 82:1990;699.
137. Morimoto A., Okamura K., Hamanaka R. et al. Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture. Biochem Biophys Res Commun. 179:1991;1042-1049.
138. Silvagno F., Follenzi A., Arese M. et al. In-vivo activation of met tyrosine kinase by heterodimeric hepatocyte growth-factor molecule promotes angiogenesis. Arterioscler Thromb Vascul Biol. 15:1995;1857-1865.
139. Nakamura Y., Morishita R., Higaki J. et al. Hepatocyte growth-factor is a novel member of the endothelium-specific growth-factors-additive stimulatory effect of hepatocyte growth-factor with basic fibroblast growth-factor but not with vascular endothelial growth-factor. J Hypertens. 14:1996;1067-1072.
140. Laterra J., Nam M., Rosen E. et al. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest. 76:1997;565-577.
141. Lamszus K., Jin L., Fuchs A. et al. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest. 76:1997;339-353.
142. Nakamura Y., Morishita R., Higaki J., Kida I., Aoki M., Moriguchi A., Yamada K., Hayashi Si., Yo Y., Matsumoto K., Nakamura T., Ogihara T. Expression of local hepatocyte growth-factor system in vascular tissues. Biochem Biophys Res Commun. 215:1995;483-488.
143. Rosen E.M., Meromsky L., Setter E. et al. Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis. 10:1990;49-64.
144. Rosen E.M., Knesel J., Goldberg I.D. et al. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer. 57:1994;706-714.
145. Rong S., Bodescot M., Blair D. et al. Tumorigenicity of the met protooncogene and the gene for hepatocyte growth factor. Mol Cell Biol. 12:1992;5152-5158.
146. Gohji K., Nakajima M., Fabra A. et al. Regulation of gelatinase production in metastatic penal cell-carcinoma by organ-specific fibroblasts. Japn J Cancer Res. 85:1994;152-160.
147. Camussi G., Montrucchio G., Lupia E. et al. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J Immunol. 158:1997;1302-1309.
148. Yamashita J., Ogawa M., Yamashita S. et al. Immunoreactive hepatocyte growth-factor is a strong and independent predictor of recurrence and survival in human breast-cancer. Cancer Res. 54:1994;1630-1633.
149. Taniguchi T., Toi M., Inada K. et al. Serum concentrations of hepatocyte growth-factor in breast-cancer patients. Clin Cancer Res. 1:1995;1031-1034.
150. Taniguchi T., Toi M., Tominaga T. Increase in the circulating level of hepatocyte growth-factor in breast-cancer patients with distant metastases. Oncol Rep. 1:1994;1199-1201.
151. Liang T.J., Reid A.E., Xavier R. et al. Transgenic expression of tpr-MET oncogene leads to development of mammary hyperplasia and tumors. J Clin Invest. 97:1996;2872-2877.
152. Rao U.N.M., SonmezAlpan E., Michalopoulos G.K. Hepatocyte growth factor and c-met in benign and malignant peripheral nerve sheath tumors. Human Pathol. 28:1997;1066-1070.
153. Johnson M., Koukoulis G., Kochhar K. et al. Selective tumorigenesis in nonparenchymal liver epithelial-cell lines by hepatocyte growth-factor transfection. Cancer Lett. 96:1995;37-48.
154. Takayama H., LaRochelle W.J., Sharp R. et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor scatter factor. Proc Natl Acad Sci USA. 94:1997;701-707.
155. Yasunaga Y., Shinomura Y., Kanayama S. et al. Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut. 39:1997;787-794.
156. Empereur S., Djelloul S., DiGioia Y. et al. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion. Br J Cancer. 75:1997;241-250.
157. Sakata H., Takayama H., Sharp R. et al. Hepatocyte growth-factor scatter factor overexpression induces growth, abnormal-development, and tumor-formation in transgenic mouse livers. Cell Growth Different. 7:1996;1513-1523.
158. Burr A.W., Hillan K.J., Mclaughlin K.E. et al. Hepatocyte growth-factor levels in liver and serum increase during chemical hepatocarcinogenesis. Hepatology. 24:1996;1282-1287.
159. Santonirugiu E., Preisegger Kh., Kiss A. et al. Inhibition of neoplastic development in the liver by hepatocyte growth-factor in a transgenic mouse model. Proc Natl Acad Sci USA. 93:1996;9577-9582.
160. Thorgeirsson S.S., Santonirugiu E. Transgenic mouse models in carcinogenesis-interaction of c-myc with transforming growth-factor-alpha and hepatocyte growth-factor in hepatocarcinogenesis. Br J Pharmacol. 42:1996;43-52.
161. Hu Z.Y., Evarts R.P., Fujio K. et al. Expression of transforming growth-factor-alpha epidermal growth-factor receptor, hepatocyte growth-factor c-met and acidic fibroblast growth-factor fibroblast growth-factor receptors during hepatocarcinogenesis. Carcinogenesis. 17:1996;931-938.
162. Imai T., Masui T., Nakanishi H. et al. Expression of hepatocyte growth-factor and c-met messenger-RNAs during rat chemically-induced hepatocarcinogenesis. Carcinogenesis. 17:1996;19-24.
163. Furukawa T., Duguid W.P., Kobari M. et al. Hepatocyte growth-factor and met receptor expression in human pancreatic carcinogenesis. Am J Pathol. 147:1995;889-895.
164. Yonemura Y., Nojima N., Kaji M. et al. E-cadherin and c-met expression as a prognostic factor in gastric cancer. Oncol Rep. 4:1994;743-748.
165. Grobstein C. Mechanisms of organotypic tissue interactions. Natl Cancer Inst Monogr. 26:1967;917-926.
166. Sakakura T. New aspects of stroms-parenchyma relations in mammary gland differentiation. Int Rev Cytol. 125:1991;165-202.
167. Birchmeier C., Birchmeier W. Molecular aspects of mesenchymal-epithelial interactions. Ann Rev Cell Biol. 9:1993;511-540.
168. Sonnenberg E., Meyer D., Weidner K.M. et al. Scatter factor\hepatocyte growth factor and its receptor, the c-met tyrosine kinase can mediate a signal exhange between mesenchymal and epithelia during mouse development. J Cell Biol. 123:1993;223-235.
169. Schmidt C., Bladt F., Goedecke S. et al. Scatter factor/hepatocyte growth-factor is essential for liver development. Nature. 373:1995;699-702.
170. Uehara Y., Minowa O., Mori C. et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature. 373:1995;702-705.
171. Santos O.F.P., Barros E.J.G., Yang X. et al. Involvement of hepatocyte growth factor in kidney development. Dev Biol. 163:1994;525-529.
172. Woolf A.S., Kolatsijoannou M., Hardman P. et al. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol. 128:1995;171-184.
173. Soriano J.V., Pepper M.S., Nakamura T. et al. Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J Cell Sci. 108:1995;413-430.
174. Niranjan B., Buluwela L., Yant J. et al. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development. 121:1995;2897-2908.
175. Yang Y.M., Spitzer E., Meyer D. et al. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol. 131:1995;215-226.
176. Ohmichi H., Koshimizu U., Matsumoto K., Nakamura T. Hepatocyte growth factor (HGF) acts as a mesenchymal-derived morphogenic factor during fetal lung development. Development 1998;125:1315-24.
177. Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem. 119:1996;591-600.
178. Matsumoto K., Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun. 239:1997;639-644.
179. van den Hoff A. Stromal involvement in malignant growth. Adv Cancer Res. 50:1998;159-196.
180. Picard O., Rolland Y., Poupon M.F. Fibroblast-dependent tumorigenecity of cells in nude mice: implication for implantation of metastases. Cancer Res. 46:1986;3290-3294.
181. Grey A.M., Schor A.M., Rushton G. et al. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA. 86:1989;2438-2442.
182. Matsumoto K., Horikoshi M., Rikimaru K., Enomoto S. A study of an in vitro model for invasion of oral squamous cell carcinoma. J Oral Pathol Med. 18:1989;498-501.
183. Camps J.L., Chang S., Hsu T.C. et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA. 87:1990;75-79.
184. Gherardi E., Grey J., Stoker M. et al. Purification of scatter factor, a fibroblast-derived basic protein which modulates epithelial interactions and movement. Proc Natl Acad Sci USA. 86:1989;5844-5848.
185. Inoue T., Chung Y.S., Yashiro M. et al. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res. 88:1997;152-159.
186. Schor S.L., Schor A.M., Winn B., Rushton G. The use of three dimensional gells for study of tumor cell invasion in vitro. Int J Cancer. 29:1982;57-62.
187. Shimura H., Date K., Matsumoto K. et al. Induction of invasive growth in a gallbladder cancer cell-line by hepatocyte growth-factor in-vitro. Jpn J Cancer Res. 86:1995;662-669.
188. Seslar S.P., Nakamuran T., Byers S.W. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res. 53:1993;1233-1238.
189. Rosen E.M., Joseph A., Jin L. et al. Regulation of scatter factor production via a soluble inducing factor. J Cell Biol. 127:1994;225-234.
190. Matsumoto K., Okazaki H., Nakamura T. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun. 188:1992;235-243.
191. Matsumoto K., Nakamura T. Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth-factor. Biochem Biophys Res Commun. 227:1996;455-461.
192. Matsumoto K., Tajima H., Okazaki H., Nakamura T. Heparin as an inducer of hepatocyte growth-factor. J Biochem. 114:1993;820-826.
193. Nakamura T., Matsumoto K., Kiritoshi A. et al. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57:1997;3305-3313.
194. Gohda E., Matsunaga T., Kataoka H. et al. Induction of hepatocyte growth-factor in human skin fibroblasts by epidermal growth-factor, platelet-derived growth-factor and fibroblast growth-factor. Cytokine. 6:1994;633-640.
195. Roletto F., Galvani A.P., Cristiani C. et al. Basic fibroblast growth factor stimulates hepatocyte growth factor\scatter factor secretion by human mesenchymal cells. J Cell Physiol. 166:1996;105-111.
196. Matsumoto K., Okazaki H., Nakamura T. Novel function of prostaglandins as inducers of gene-expression of HGF and putative mediators of tissue regeneration. J Biochem. 117:1995;458-464.
197. Matsumoto K., Date K., Shimura H., Nakamura T. Acquisition of invasive phenotype in gallbladder cancer-cells via mutual interaction of stromal fibroblasts and cancer-cells as mediated by hepatocyte growth-factor. Jpn J Cancer Res. 87:1996;702-710.
198. Matsumoto K., Date K., Ohmichi H., Nakamura T. Hepatocyte growth-factor in lung morphogenesis and tumor invasion-role as a mediator in epithelium-mesenchyme and tumor-stroma interactions. Cancer Chemother Pharmacol. 38:1996;S42-S47.
199. Kato S., Ishii T., Hara H. et al. Hepatocyte growth-factor immobilized onto culture substrates through heparin and matrigel enhances dna-synthesis in primary rat hepatocytes. Exp Cell Res. 211:1994;53-58.
200. Lamszus K., Joseph A., Jin L. et al. Scatter factor binds to thrombospondin and other extracellular-matrix components. Am J Pathol. 149:1996;805-819.
201. Lyon M., Deakin J.A., Mizuno K. et al. Interaction of hepatocyte growth factor with heparin sulfate. Elucidation of the major heparin sulfate structural determinants. J Biol Chem. 269:1994;11216-11223.
202. Moriyama T., Kataoka H., Tsubouchi H., Koono M. Concomitant expression of hepatocyte growth-factor (HGF), HGF activator and c-met genes in human glioma-cells in-vitro. Cancer Lett. 372:1995;78-82.
203. Shima N., Nagao M., Ogaki F. et al. Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein. Biochem Biophys Res Commun. 80:1991;1151-1158.
204. Noji S., Tashiro K., Koyama E. et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer's cells of damaged rat livers as revealed by in situ hybridisation. Biochem Biophys Res Commun. 173:1990;42-47.
205. Ramadori G., Neubauer K., Odenthal M. et al. The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is down regulated during cell growth and by transforming growth factor beta. Biochem Biophys Res Commun. 183:1992;739-742.
206. Schirmacher P., Geerts A., Pietrangelo A. et al. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology. 15:1992;5-11.
207. Yoshinaga Y., Fujita S., Gotoh M. et al. Human lung cancer cell-line producing hepatocyte growth factor/scatter factor. Jpn J Cancer Res. 83:1992;1257-1261.
208. Rygaard K., Nakamura T., Spang-Thomsen M. Expression of the proto-oncogene c-met and c-kit and their ligands, hepatoycte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer. 67:1993;37-46.
209. Tsao M.S., Shu H., Giaid A.V. et al. Hepatocyte growth-factor/scatter factor (HGF/SF) is an autocrine factor expressed by human normal bronchial epithelial (NSB) and nonsmall cell lung-carcinoma (NSCLC) cells. FASEB J. 7:1993;429.
210. Miyazaki M., Bai L., Taga H. et al. Expression of liver-specific functions and secretion of a hepatocyte growth factor by a newly established rat hepatoma-cell line growing in a chemically-defined serum free medium. Res Exp Med. 191:1991;297-307.
211. Hirota M., Egami H., Corra S. et al. Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line. Carcinogenesis. 14:1993;259-264.
212. Tsubouchi H., Hirono S., Gohda E. et al. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology. 9:1989;875-881.
213. Tomoaki T., Nagoshi S., Fujiwara K. Significance of serum hepatocyte growth factor levels in patients with hepatic failure. Hepatology. 15:1992;1-4.
214. Kaneko A., Hayashi N., Tanaka Y. et al. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolisation and partial hepatectomy. Am J Gastroentrol. 87:1992;1014-1017.
215. Taniguchi T., Kitamura M., Arai K. et al. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer. 75:1997;673-677.
216. Tamura M., Arakaki N., Tsoubouchi H. et al. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and 1-beta and tumour necrosis factor-alpha by fibroblasts in culture. J Biol Chem. 268:1993;8140-8145.
217. Gohda E., Matsumoto T., Kataoka H., Yamamoto I. TGF-β is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int Rep. 16:1992;917-926.
218. Matsumoto K., Tajima H., Okazaki H., Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor β1 and glucocorticoids. J Biol Chem. 267:1992;24917-24920.
219. Matsumoto K., Tajima H., Hamanoue M. et al. Identification and characterization of injurin, an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci USA. 89:1992;3800-3804.
220. Matsumoto K., Tajima H., Hamanoue M. et al. Identification and characterization of injurin, an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci USA. 89:1992;3800-3804.
221. Matsunaga T., Gohda E., Takebe T. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway. Exp Cell Res. 210:1994;326-335.
222. Okazaki H., Matsumoto K., Nakamura T. Partial-purification and characterization of injurin-like factor which stimulates production of hepatocyte growth-factor. Biochim Biophys Acta. 1220:1994;291-298.
223. Seslar S., Nakamura T., Byers S. Tumor-stroma interactions and stromal cell-density regulate hepatocyte growth-factor protein-levels-a role for transforming growth-factor-beta activation. Endocrinology. 136:1995;1945-1953.
224. Jiang J.G., Zarnegar R. A novel transcriptional regulatory region within the core promoter of the hepatocyte growth factor gene is responsible for its inducibility by cytokines via the C/EBP family of transcription factors. Mol Cell Biol. 17:1997;5758-5770.
225. Li D.Q., Tseng S.C.G. Differential regulation of keratinocyte growth factor and hepatocyte growth factor scatter factor by different cytokines in human corneal and limbal fibroblasts. J Cell Physiol. 172:1997;361-372.
226. Yamazaki H., Oi H., Matsushita M. et al. Heparin induces rapid and remarkable elevation of hepatocyte growth factor scatter factor during trans arterial embolization of renal cell carcinoma. Anticancer Res. 17:1997;1435-1437.
227. Gambarotta G., Boccaccio C., Giordano S. et al. ETS up-regulates met transcription. Oncogene. 13:1996;1911-1917.
228. Puntis M.C.A., Hallett M.B., Jiang W.G. Modulation by cytokines of hepatocyte growth factor/scatter factor production by fibroblasts. HPB Surg. 9:1995;101.
229. Sugiyama A., Arakaki R., Ohnishi T. et al. Lipoteichoic acid and interleukin-1 stimulate synergistically production of hepatocyte growth-factor (scatter factor) in human gingival fibroblasts in culture. Infect Immun. 64:1996;1426-1431.
230. Jiang J.G., Bell A., Liu Y.H., Zarnegar R. Transcriptional regulation of the hepatocyte growth factor gene by the nuclear receptors chicken ovalbumin upstream promoter transcription factor and estrogen receptor. J Biol Chem. 272:1997;3928-3934.
231. Metcalfe A.M.J., Dixon R.M., Radda G.K. Wild-type but not mutant p53 activates the hepatocyte growth factor scatter factor promoter. Nucleic Acid Res. 25:1997;983-986.
232. Kinoshita T., Tashito K., Nakamjura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun. 165:1989;1229-1234.
233. Lindroos P., Tsai W.H., Zarnegar R., Michalopoulos G.K. Plasma levels of HGF in rats treated with tumor promoters. Carcinogenesis. 13:1992;139-141.
234. Lindroos P.M., Zarnegar R., Michalopoulos G.K. Hepatocyte growth factor (hepatopoitin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulation by partial hepatectomy and carbon tetrachhloride administration. Hepatology. 13:1991;743-749.
235. Hamanoue M., Kawaida K., Takano S. et al. Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology. 16:1992;1485-1492.
236. Plaschkeschlutter A., Behrens J., Gherardi E., Birchmeier W. Characterization of the scatter factor hepatocyte growth-factor gene promoter-positive and negative regulatory elements direct gene-expression to mesenchymal cells. J Biol Chem. 270:1995;830-836.
237. Hiscox S., Hallett M.B., Puntis M.C.A. et al. Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancer. Cancer Invest. 15:1997;513-521.
238. Direnzo M.F., Olivero M., Serini G. et al. Overexpression of the c-met/HGF receptor in human thyroid carcinomas derived from the follicular epithelium J Endocrinol Invest. 18:1995;134-139.
239. Direnzo M.F., Olivero M., Giacomini A. et al. Overexpression and amplification of the MET/HGF receptor gene during the progression of colorectal-cancer. Clin Cancer Res. 1:1995;147-152.
240. Sasaki M, Nishio M, Sasaki T, Enami J. Identification of mouse mammary fibroblast-derived mammary growth-factor as hepatocyte growth-factor. Biochem Biophys Res Commun 1992;772-779.
241. Di Renzo M.F., Narsiman R.P., Olivero M. et al. Expression of the MET/HGF receptor in normal and neoplastic human tissues. Oncogene. 6:1991;1997-2003.
242. Direnzo M.F., Poulsom R., Olivero M. et al. Expression of the met hepatocyte growth-factor receptor in human pancreatic-cancer. Cancer Res. 55:1995;1129-1138.
243. Fushida S., Yonemura Y., Urano T. et al. Expression of hepatocyte growth factor(HGF) and c-met gene in human gastric-cancer cell-lines. Int J Oncol. 3:1993;1067-1070.
244. Itakura Y., Yamamoto T., Matsumoto K., Nakamura T. Autocrine stimulation of motility in sbc-5 human lung-carcinoma cells by a 2-kringle variant of HGF. Cancer Lett. 83:1994;235-243.
245. Ebert M., Yokoyama M., Friess H. et al. Coexpression of the c-met protooncogene and hepatocyte growth-factor in human pancreatic-cancer. Cancer Res. 54:1994;5775-5778.
246. Bellusci S., Moens G., Gaudino G. et al. Creation of an hepatocyte growth-factor scatter factor autocrine loop in carcinoma-cells induces invasive properties associated with increased tumorigenicity. Oncogene. 9:1994;1091-1099.
247. Borset M., Lien E., Espevik T. et al. Concomitant expression of hepatocyte growth-factor scatter factor and the receptor c-met in human myeloma cell-lines. J Biol Chem. 271:1996;24655-24661.
248. Jin L., Fuchs A., Schnitt S.J. et al. Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer. 79:1997;749-760.
249. Ljubimova J.Y., Petrovic L.M., Wilson S.E.G. et al. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem. 45:1997;79-87.
250. Olivero M., Rizzo M., Madeddu R. et al. Overexpression and activation of hepatocyte growth factor scatter factor in human non-small-cell lung carcinomas. Br J Cancer. 74:1996;1862-1868.
251. Jeffers M., Rong S., Anver M., Vandewoude G.F. Autocrine hepatocyte growth-factor scatter factor-met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene. 13:1996;853-861.
252. Joseph A., Weiss Gh, Jin L. et al. Expression of scatter factor in human bladder-carcinoma. J Natl Cancer Inst. 87:1995;372-377.
253. Tuck A.B., Park M., Sterns E.E. et al. Coexpression of hepatocyte growth-factor and receptor (met) in human breast-carcinoma. Am J Pathol. 148:1996;225-232.
254. Ferracini R., Direnzo M.F., Scotlandi K. et al. The met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene. 10:1995;739-749.
255. Hayashi S., Morishita R., Higaki J. et al. Autocrine paracrine effects of overexpression of hepatocyte growth- factor gene on growth of endothelial-cells. Biochem Biophys Res Commun. 220:1996;539-545.
256. Nakamura T., Nawa K., Ichihara A. et al. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224:1987;311-318.
257. Miyazawa K., Trubouchi H., Naka D.T. et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun. 163:1989;967-973.
258. Hartmann G., Naldini L., Weidner M. et al. A functional domain in the heavy chain of scatter factor\hepatocyte growth factor binds the c-met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci USA. 89:1992;11574-11578.
259. Shimomura T., Miyazawa K., Komiyama Y. et al. Activation of hepatocyte growth-factor by 2 homologous proteases, blood-coagulation factor-xiia and hepatocyte growth-factor activator. Eur J Biochem. 229:1995;257-261.
260. Miyazawa K, Shimomura T, Kitamura N. Activation of hepatocyte growth-factor in the injured tissues is mediated by hepatocyte growth-factor activator. J Biol Chem 1996;271:3615-3618.
261. Masumoto A., Yamamoto N. Sequestration of a hepatocyte growth-factor in extracellular-matrix in normal adult-rat liver. Biochem Biophys Res Commun. 174:1991;90-95.
262. Liu Xl, Wazer De, Watanabe K., Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast-cancer progression. Cancer Res. 56:1996;3371-3379.
263. Hiscox S, Davies EL, Jiang WG. Up regulation of the expression of hepatocyte growth factor activator (HGFA) in breast cancer. Br J Cancer, 1998;78:150.
264. Moghul A., Lin L., Beedle A. et al. Modulation of c-met protooncogene (hgf receptor) messenger-RNA abundance by cytokines and hormones-evidence for rapid decay of the 8 kb c-met transcript. Oncogene. 9:1994;2045-2052.
265. Boccaccio C., Gaudino G., Gambarotta G. et al. Hepatocyte growth-factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. J Biol Chem. 269:1994;12846-12851.
266. Galvani Ap, Cristiani C., Carpinelli P., Landonio A., Bertolero F. Suramin modulates cellular-levels of hepatocyte growth-factor receptor by inducing shedding of a soluble form. Biochem Pharmacol. 50:1995;959-966.
267. Jeffers M., Taylor G.A., Weidner K.M. et al. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol. 17:1997;799-808.
268. Ratajczak M.Z., Marlicz W., Ratajczak J. et al. Effect of hepatocyte growth factor on early human haemopoietic cell development. Br J Haematol. 99:1997;228-236.
269. Galimi F., Bagnara G.P., Bonsi L. et al. Hepatocyte growth-factor induces proliferation and differentiation of multipotent and erythroid hematopoietic progenitors. J Cell Biol. 127:1994;1743-1754.
270. Borset M., Hjorthhansen H., Seidel C. et al. Hepatocyte growth-factor and its receptor c-met in multiple-myeloma. Blood. 88:1997;3998-4004.
271. Hino M., Inaba M., Goto H. et al. Hepatocyte growth-factor levels in bone-marrow plasma of patients with leukemia and its gene-expression in leukemic blast cells. Br J Cancer. 73:1996;119-123.
272. Ueki T., Fujimoto J., Suzuki T. et al. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Hepatology. 25:1997;619-623.
273. Shiota G., Kawasaki H., Nakamura T.S. et al. Inhibitory effect of hepatocyte growth-factor on metastasis of hepatocellular-carcinoma in transgenic mice. Res Commun Mol Pathol Pharmacol. 91:1996;33-39.
274. Selden C., Farnaud S., Ding S.f. et al. Expression of hepatocyte growth-factor messenger-rna, and c-met messenger-rna (hepatocyte growth-factor receptor) in human liver-tumors. J Hepatol. 21:1994;227-234.
275. Ng E.H., Pey H.B., Law H.Y. et al. Loss of c-met protooncogene in primary and metastatic sites of breast cancer. Ann Surg Oncol. 4:1997;499-502.
276. Yonemura Y., Kaji M., Hirono Y. et al. Correlation between overexpression of c-met gene and the progression of gastric-cancer. Int J Oncol. 8:1996;555-560.
277. Iwazawa T., Shiozaki H., Doki Y. et al. Primary human fibroblasts induce diverse tumor invasiveness-involvement of HGF as an important paracrine factor. Jpn J Cancer Res. 87:1996;1134-1142.
278. Fujita S., Sugano K. Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases. Jpn J Clin Oncol. 27:1997;378-383.
279. Rosen E.M., Joseph A., Jin L. et al. Urinary and tissue-levels of scatter factor in transitional-cell carcinoma of bladder. J Urol. 157:1997;72-78.
280. Belfiore A., Gangemi P., Costantino A. et al. Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab. 82:1997;2322-2328.
281. Ruco L.P., Ranalli T., Marzullo A. et al. Expression of met protein in thyroid-tumors. J Pathol. 180:1997;266-270.
282. Saitoh K., Takahashi H., Sawada N., Parsons P.G. Detection of the c-met protooncogene product in normal skin and tumors of melanocytic origin. J Pathol. 174:1994;191-199.
283. Natali P.G., Nicotra M.R., Di Renzo M.F. et al. Expression of the cMET/HGF receptor in human melanocytic meoplasmas. Br J Cancer. 68:1993;746-750.
284. Siegfried J.M., Weissfeld L.A., Singh Kaw P. et al. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res. 57:1997;433-439.
285. Takanami I., Tanana F., Hashizume T. et al. Hepatocyte growth-factor and c-met/hepatocyte growth-factor receptor in pulmonary adenocarcinomas-an evaluation of their expression as prognostic markers. Oncology. 53:1996;392-397.
286. Takigawa N., Segawa Y., Maeda Y. et al. Serum hepatocyte growth factor scatter factor levels in small cell lung cancer patients. Lung Cancer. 17:1997;211-218.
287. Janeko A., Hayashi N., Tanaka Y. et al. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy. Am J Gastroenterol. 87:1992;1014-1017.
288. Eagles G., Warn A., Ball R.Y. et al. Hepatocyte growth-factor scatter factor is present in most pleural effusion fluids from cancer-patients. Br J Cancer. 73:1996;377-381.
289. Koochekpour S., Jeffers M., Rulong S. et al. Met and hepatocyte growth factor scatter factor expression in human gliomas. Cancer Res. 57:1997;5391-5398.
290. Jeffers M., Schmidt L., Nakaigawa N. et al. Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA. 94:1997;11445-11450.
291. Prat M., Crepaldi T., Gandino L. et al. C-terminal truncated forms of met, the hepatocyte grwoth factor receptor. Mol Cell Biol. 11:1991;5954-5962.
292. Rodrigues G.A., Naujokas M.A., Park M. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergoes differential processing. Mol Cell Biol. 11:1991;2962-2970.
293. Crepaldi T., Prat M., Giordano S. et al. Generation of a truncated hepatocyte growth-factor receptor in the endoplasmic-reticulum. J Biol Chem. 269:1994;1750-1755.
294. Downing J.R., Roussel M.F., Sherr C.J. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol Cell Biol. 9:1989;2890-2896.
295. Prat M., Narsimhan R.P., Crepaldi T. et al. The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumours. Int J Cancer. 49:1991;323-328.
296. Gandino L., Longati P., Medico E. et al. Phosphorylation of serine-985 negatively regulates the hepatocyte growth-factor receptor kinase. J Biol Chem. 269:1994;1815-1820.
297. Lee C.C., Yamada K.M. Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site-deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-oh kinase to the hepatocyte growth-factor receptor. J Biol Chem. 270:1995;507-510.
298. Zhen Z., Giordano S., Longati P. et al. Structural and functional domains critical for constitutive activation of the HGF receptor (met). Oncogene. 9:1994;1691-1697.
299. Ichimura E., Maeshima A., Nakajima T., Nakamura T. Expression of c-met/hgf receptor in human nonsmall cell lung carcinomas in-vitro and in-vivo and its prognostic-significance. Jpn J Cancer Res. 87:1996;1063-1069.
300. Scotlandi K., Baldini N., Oliviero M. et al. Expression of met/hepatocyte growth-factor receptor gene and malignant behavior of musculoskeletal tumors. Am J Pathol. 149:1996;1209-1219.
301. Pisters L.L., Troncoso P., Zhau H.E. et al. c-met protooncogene expression in benign and malignant human prostate tissues. J Urol. 154:1995;293-298.
302. Yao Y., Jin L., Fuchs A. et al. Scatter factor protein-levels in human breast cancers-clinicopathological and biological correlations. Am J Pathol. 149:1996;1707-1717.
303. Uchiyama A., Essner R., Doi F. et al. Interleukin-4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas. J Cell Biochem. 62:1996;443-453.
304. Hiscox S., Jiang W.G. Interleukin-12, an emerging anti-tumour cytokine. In vivo. 11:1997;125-132.
305. Hiscox S., Puntis M.C.A., Hallett M.B., Jiang W.G. Inhibition of motility and invasion of human colon cancer cells by interleukin-12. Clin Exp Metastas. 13:1995;396-404.
306. Begin M.E., Ells G., Das U.N., Horrobin D.F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 77:1986;1053-1062.
307. Horrobin D.F. Essential fatty acids, lipid peroxidation, and cancer. Horrobin D.F. Omega-6 Essential Fatty Acids. 1990;351-378 Wiley, New York.
308. Jiang WG, Bryce RP and Horrobin DF. Essential fatty acids, the molecular and cellular mechanisms of their anticancer action and clinical implications. Crit Rev Oncol/Haematol, 1998;27:179-209.
309. Jiang WG, Hiscox S, Hallett MB, et al. Inhibition of invasion and motility of human colon cancer cells by gamma linolenic acid. Br J Cancer 71:744-752.
310. Jiang W.G., Hiscox S., Hallett M.B. et al. Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid. Cancer Res. 55:1995;5043-5048.
311. Jiang W.G., Hiscox S., Puntis M.C.A. et al. Gamma linolenic acid (GLA) inhibits tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin and tumour cell-matrix interaction. Int Jf Oncol. 8:1996;583-587.
312. Chan A.M.L., Rubin J.S., Bottaro D.P. et al. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science. 254:1991;1382-1385.
313. Cioce V., Csaky K.G., Chan A.M.L. et al. Hepatocyte growth-factor (HGF)/NK1 is a naturally-occurring HGF scatter factor variant with partial agonist-antagonist activity. J Biol Chem. 271:1996;13110-13115.
314. Schwall R.H., Chang L.Y., Godowski P.J. et al. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth-factor antagonists NK1 and NK2. J Cell Biol. 133:1996;709-718.
315. Date K., Matsumoto K., Shimura H. et al. HGF\NK4 is a specific antagonist for pleiotrophic actions of hepatocye growth factor. FEBS Lett. 420:1997;1-6.
316. Takeuchi K., Shibamoto S., Hayakawa M. et al. Hepatocyte growth-factor (HGF)-induced cell-migration is negatively modulated by epidermal growth-factor through tyrosine phosphorylation of the HGF receptor. Exp Cell Res. 223:1996;420-425.
317. Shimomura T., Denda K., Kitamura A. et al. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem. 272:1997;6370-6376.
318. Kawaguchi T., Qin L., Shimomura T. et al. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem. 272:1997;27558-27564.
319. Hordijk P.L., tenKlooster J.P., vanderKammen R.A. et al. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science. 278:1997;1464-1466.
320. Isoai A., Giga-Hama Y., Shinkai K. et al. Purification and characterisation of tumout invasion-inhibiting factors. Jpn J Cancer Res. 81:1992;909-914.
321. Isoai A., Goto-Tsukamoto H., Akedo H., Kumagi H. A potent anti-metastatic activity of tumour invasion-inhibiting factor-2 and albumin conjugate. Biochem Biophy Res Commun. 192:1993;7-14.
322. Isoai A., Gototsukamoto H., Yamori T. et al. Inhibitory effects of tumor invasion-inhibiting factor-2 and its conjugate on disseminating tumor-cells. Cancer Res. 54:1994;1264-1270.
323. Jiang W.G., Hiscox S., Singhrao S.K. et al. Inhibition of motility and invasion by invasion inhibiting factor 2 on human colon cancer cells. Surg Res Commun. 17:1995;67-78.
324. Han Z.G., Jiang W.G., Hallett M.B. et al. Inhibition of motility, dissociation, and invasion of human lung cancer cells by invasion inhibiting factor 2. Surg Oncol. 5:1996;77-84.
325. Koj A., Guzdek A., Nakamura T., Kordula T. Hepatocyte growth-factor and retinoic acid exert opposite effects on synthesis of type-1 and type-2 acute-phase proteins in rat hepatoma-cells. Int J Biochem Cell Biol. 27:1995;39-46.
326. Edward M., Gold J.A., Mackie R.M. Modulation of melanoma cell adhesion to basement membrane components by retinoic acid. J Cell Biol. 93:1989;155-161.
327. Hendrx M.J., Wood W.R., Sefter E.A. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res. 50:1990;4121-4130.
328. Lotan R., Amos B., Watanabe J., Raz A. Suppression of melanoma cell motility factor recceptor expression by retinoic acid. Cancer Res. 52:1992;4852-4878.
329. Hiscox S., Jiang W.G. Quantitation of tumour-endothelial interaction with DiI, 1,1′-dioctadecyl-3,3,3′,3′ tetrametryllindocarbocyanine (DiI). Cancer Lett. 112:1997;209-217.
330. Direnzo M.F., Olivero M., Katsaros D. et al. Overexpression of the met HGF receptor in ovarian-cancer. Int J Cancer. 58:1994;658-662.
331. Naidu Y.M., Rosen E.M., Zitnick R. et al. Role of scatter factor in the pathogenesis of aids-related kaposi-sarcoma. Proc Natl Acad Sci USA. 91:1994;5281-5285.
332. Maier J.A.M., Mariotti M., Albini A. et al. Over-expression of hepatocyte growth-factor in human kaposis-sarcoma. Int J Cancer. 65:1996;168-172.
333. Beviglia L., Matsumoto K., Lin C.S., Ziober B.L., Kramer R.H. Expression of the c-met/HGF receptor in human breast carcinoma: Correlation with tumor progression. Int J Cancer. 74:1997;301-309.
334. Laterra J., Rosen E., Nam M. et al. Scatter factor hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem Biophys Res Commun. 235:1997;743-747.
335. Lamszus K., Schmidt N.O., Jin L. et al. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer. 75:1998;19-28.
336. Yamamoto S., Wakimoto H., Aoyagi M. et al. Modulation of motility and proliferation of glioma cells by hepatocyte growth factor. Jpn J Cancer Res. 88:1997;564-577.
337. Moriyama T., Kataoka H., Seguchi K. et al. Effects of hepatocyte growth-factor (HGF) on human glioma-cells in-vitro-hgf acts as a motility factor in glioma-cells. Int J Cancer. 66:1996;678-685.
338. Matsumoto K., Kagoshima M., Nakamura T. Hepatocyte growth-factor as a potent survival factor for rat pheochromocytoma pc12 cells. Exp Cell Res. 220:1995;71-78.
339. Li Y., Bhargava M.M., Joseph A. et al. Effect of hepatocyte growth-factor scatter factor and other growth-factors on motility and morphology of nontumorigenic and tumor-cells. In Vitro Cell Cevelp Biol. 30A:1994;105-110.
340. Afford Sc., Kakoullis T., Oates J. et al. Effects of hepatocyte growth-factor on differentiation and cmet receptor expression in the promyelocytic HL-60 cell-line. J Clin Pathol. 48:1995;M23-M27.
341. Jucker M., Gunther A., Gradl G. et al. The MET/hepatocyte growth-factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma. Leuk Res. 18:1994;7-16.
342. Nakayama Y., Naito S., Ryuto M. et al. An in-vitro invasion model for human renal-cell carcinoma cell-lines mimicking their metastatic abilities. Clin Exp Metastasis. 14:1996;466-474.
343. Natali P.G., Prat M., Nicotra M.R. et al. Overexpression of the met/hgf receptor in renal-cell carcinomas. Int J Cancer. 69:1996;212-217.
344. Rosen E.M., Laterra J., Joseph N. et al. Scatter factor expression and regulation in human glial tumors. Int J Cancer. 67:1996;248-255.
345. Vila M.R., Nakamura T., Real F.X. Hepatocyte growth-factor is a potent mitogen for normal human pancreas cells in-vitro. Lab Invest. 73:1995;409-418.
346. Tani T., Lumme A., Linnala A. et al. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am J Pathol. 151:1997;1289-1302.
347. Kiehne K., Herzig K.H., Folsch U.R. c-met Expression in pancreatic cancer and effects of hepatocyte growth factor on pancreatic cancer cell growth. Pancreas. 15:1997;35-40.
348. Livant D.L., Linn S., Markwart S., Shuster J. Invasion of selectively permeable sea-urchin embryo basement- membranes by metastatic tumor-cells, but not by their normal counterparts. Cancer Res. 55:1995;5085-5093.
349. Dignass A.U., Lynchdevaney K., Podolsky D.K. Hepatocyte growth-factor scatter factor modulates intestinal epithelial-cell proliferation and migration. Biochem Biophys Res Commun. 202:1994;701-709.
350. Hu M., Pollock Re., Nakamura T., Nicolson Gl. Human peri-tumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell trains. Int J Cancer. 62:1995;585-592.
351. Davies G, Jiang WG, Mason M. Cell-cell adhesion molecule and their associated molecules in bladder cancer cell and their role in motogen induced cell-cell dissociation and invasion. Proc Am Assoc Cancer Res 1998;39:400-1.
352. Ferracini R., Olivero M., Direnzo M.F. et al. Retrogenic expression of the met protooncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene. 12:1996;1697-1705.
353. Krasnoselsky A., Massay M.J., Defrances M.C. et al. Hepatocyte growth-factor is a mitogen for Schwann-cells and is present in neurofibromas. J Neurosci. 14:1994;7284-7290.
354. Shiota G., Kawasaki H., Nakamura T. Coexpression of hepatocyte growth-factor and its receptor (c-met oncogene) in hgl4 glioblastoma cells. Oncology. 53:1996;511-516.
355. Shiota G., Nakamura T., Schmidt Ev Hepatocyte growth-factor regulates transforming growth-factor-alpha in HEPG2 hepatic cells. Biochem Biophys Res Commun. 200:1994;1099-1104.
356. Kiss A., Wang N.J., Xie J.P., Thorgeirsson S.S. Analysis of transforming growth factor (TGF)-alpha epidermal growth factor receptor, hepatocyte growth factor c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res. 3:1997;1059-1066.
357. Seidel C., Borset M., Turesson I. et al. Elevated serum concentrations of
358. Nakamura S., Gohda E., Matsuo Y. et al. Significant amount of hepatocyte growth-factor detected in blood and bone-marrow plasma of leukemia patients. Br J Haematol. 87:1994;640-642.
359. Seckl Mj, Seufferlein T., Rozengurt E. Lysophosphatidic acid-depleted serum, hepatocyte growth-factor and stem-cell growth-factor stimulate colony growth of small-cell lung-cancer cells through a calcium-independent pathway. Cancer Res. 54:1994;6143-6147.
360. Takada N., Yano Y., Matsuda T. et al. Expression of immunoreactive human hepatocyte growth-factor in human esophageal squamous-cell carcinomas. Cancer Lett. 97:1995;145-148.
361. Ueda T., Takeyama Y., Toyokawa A. et al. Significant elevation of serum human hepatocyte growth-factor levels in patients with acute-pancreatitis. Pancreas. 12:1996;76-83.
362. Wagatsuma S., Konno R., Sato S. et al. Tumor angiogenesis, hepatocyte growth factor, and c-met expression in endometrial carcinoma. Cancer. 82:1998;520-530.
363. Wu M.S., Shun C.T., Wang H.P. et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology. 112:1997;1457-1465.
364. Miller R.T., Glover S.E., Stewart W.S. et al. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver-tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator wy-14,643. Carcinogenesis. 17:1996;1337-1341.
365. Boix L., Rosa Jl, Ventura F. et al. c-met messenger-RNA overexpression in human hepatocellular-carcinoma. Hepatology. 19:1994;88-91.
366. Ueki T., Fujimoto J., Suzuki T., Yamamoto H., Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology. 25:1997;862-866.
367. Shiota G., Rhoads D.B., Wang T.C. et al. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA. 89:1992;373-377.
368. Rahimi N., Saulnier R., Nakamura T. et al. Role of hepatocyte growth-factor in breast-cancer - a novel mitogenic factor secreted by adipocytes. DNA Cell Biol. 13:1994;1189-1197.
369. Sunitha I., Meighen D.L., Hartman D.P. et al. Hepatocyte growth-factor stimulates invasion across reconstituted basement-membranes by a new human small-intestinal cell-line. Clin Exp Metastas. 12:1994;143-154.
370. Kuniyasu H., Yasui W., Shimamoto F. et al. Hepatoblastoma in an adult associated with c-met proto-oncogene imbalance. Pathol Int. 46:1996;1005-1010.
371. Weimar L.S., Miranda N., Muller E.J. et al. Hepatocyte growth-factor scatter factor (HGF/SF) promotes human hematopoietic progenitor-cell adhesion and migration. Blood. 88:1996;2125.
372. Kochhar K.S., Iyer A.P. Hepatocyte growth-factor induces activation of nck and phospholipase c-gamma in lung-carcinoma cells. Cancer Lett. 104:1996;163-169.
373. Naka T., Iwamoto Y., Shinohara N. et al. Expression of c-met proto-oncogene product (c-met) in benign and malignant bone tumors. Modern Pathol. 10:1997;832-838.
374. Halban R., Rubin J.S., Funasaka Y. et al. MET and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogenes. 7:1992;195-2206.
375. Muller D., Millon R., Eber M. et al. Alteration of the c-met oncogene locus in human head and neck-carcinoma. Oncol Rep. 2:1995;847-850.
376. Paulin C., Avallet O., Tardy F. et al. Production of TGF-beta and HGF receptor by a differentiated papillary thyroid-carcinoma cell-line (B-cPAP)-implication in malignancy. Int J Oncol. 7:1995;657-660.